Natera

Medical Director, Lung Cancer and IO

United States

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Biotechnology, Medical DevicesIndustries

Position Overview

  • Location Type: Remote with ~50% domestic and international travel
  • Job Type: [Not specified]
  • Salary: [Not specified]

The Medical Director, Oncology at Natera will provide medical expertise for the company's oncology portfolio, collaborating with cross-functional teams. The role focuses on ensuring the scientific integrity and clinical adoption of Natera’s oncology testing solutions, with a primary focus on lung cancer and immunotherapy.

Responsibilities

  • Clinical Development:
    • Collaborate with the Chief Medical Officer and other Medical Directors in Oncology on the clinical development of ctDNA-based diagnostics.
    • Lead development and implementation of clinical strategies for Natera’s oncology products, with a focus on lung cancer and immunotherapy.
  • Medical Education and Communication:
    • Oversee medical education and scientific communication for healthcare providers on Natera’s oncology offerings.
    • Partner with the commercial team to develop and deliver compelling medical messages for Natera’s oncology products.
  • Representation and Advocacy:
    • Represent Natera at medical conferences and industry events, in person and virtual.
    • Foster a culture of scientific excellence and intellectual curiosity within the oncology team.
  • Research and Development:
    • Collaborate with research and development teams on clinical trial design, data analysis, and publication.

Requirements

  • Education: M.D. or D.O. degree with board certification in Oncology (required).
  • Experience:
    • At least 5 years of experience in oncology, with a background in clinical research and development (required).
    • Clinical experience and strong knowledge in lung cancer and immunotherapy (required).
    • At least 3 years of clinical trial experience in academia, biotech industry, or equivalent (preferred).
  • Designation: Medical Director or Senior Medical Director designation commensurate with experience.

Key Skill Sets / Responsibilities

  • GU Cancer-Specific Expertise: Strong knowledge in lung cancer and immunotherapy treatment monitoring, with the ability to develop and implement strategies specific to thoracic oncology.
  • Comprehensive Oncology Knowledge: Ability to speak to all histologies and indications, ensuring broad expertise across the oncology spectrum.
  • Stay Updated: Ability to stay updated on the latest advancements in various cancer types and integrate this knowledge into Natera’s oncology products.
  • Cross-Disciplinary Collaboration: Work effectively with cross-functional teams including research, development, commercial, and medical affairs to drive the success of oncology initiatives.
  • Coordination: Coordinate with internal and external stakeholders to ensure the clinical relevance and adoption of Natera’s oncology solutions.

Company Information

  • [Not specified - Further information about Natera would be needed here.]

Skills

Oncology
Clinical Research
Clinical Trial Design
Medical Education
Scientific Communication
Immunotherapy
Lung Cancer
ctDNA Diagnostics

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters
2004Year Founded
$149.9MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Flexible medical plans
Investment options
Time off
Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
New Prospera Heart features may face slow adoption by healthcare providers.
Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
AI integration enhances accuracy and speed of Natera's cfDNA analysis.
Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI